A 45-year-old man with rare ALK-positive lung cancer that spread to the brain achieved long-term disease control after five years of treatment at a hospital in Bengaluru. With targeted therapy and multidisciplinary care, his condition stabilised, highlighting how early molecular diagnosis and advanced treatments can significantly improve survival and quality of life.